http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020146508-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b07e07ae7918451a573516faeaf0a08f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97c24af9a2d720fc0101dc74c7858f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3db7dca395c0a058f7fd39e771cb257 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dad522d02b6a7924413f903066eca955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc15eddee28e96326fba671cea9993b |
publicationDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2020146508-A |
titleOfInvention | Drug-eluting intraocular implant |
abstract | PROBLEM TO BE SOLVED: To use an implantable intraocular drug delivery device configured to target and / or control the release of a drug into a desired intraocular target tissue, and such a device for the treatment of eye diseases and disorders. Provide a method. A drug delivery intraocular implant has an optionally biodegradable elongated outer shell 54 having a first end 50 and a second end 52 and is shaped to define an internal space 58. And at least the first agent 62 placed in the internal space, one or more orifices 56a, b placed at the first end of the outer shell, and the inside of the first end of the outer shell. A permeable material 210 that is completely disposed in space and has a permeable material located between a first agent and one or more orifices, wherein the permeable material is a first. It is permeable to the drug, which allows the drug to pass through the permeable material and out of the implant through the orifice. [Selection diagram] FIG. 10C |
priorityDate | 2009-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 671.